Drivers of Orphan Drug Development

被引：6
|
作者：
Mingorance, Ana [1 ]
机构：
[1] Dracaena Consulting SL, Madrid 28036, Spain
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2018年 / 9卷 / 10期
关键词：
Orphan drug; rare disease; pipeline; personalized medicine; RESEARCH-AND-DEVELOPMENT;
D O I：
10.1021/acsmedchemlett.8b00438
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Previously neglected by the pharmaceutical industry, rare diseases and orphan drugs are rapidly becoming mainstream. Both market forces and technology enablers are responsible for this migration and combine to create multiple business approaches. This viewpoint discusses the drivers that attract different companies into this booming orphan drug space.
引用
收藏
页码：962 / 964
页数：5
相关论文
共 50 条
  • [21] The Use of Social Media in Orphan Drug Development
    Milne, Christopher-Paul
    Ni, Wendi
    CLINICAL THERAPEUTICS, 2017, 39 (11) : 2173 - 2180
  • [22] Orphan drug development in China: progress and challenges
    Zhang, Shuyang
    Chen, Limeng
    Zhang, Zongjiu
    Zhao, Yupei
    LANCET, 2019, 394 (10204): : 1127 - 1128
  • [23] Flexibility in the FDA approach to orphan drug development
    Nina L. Hunter
    Gayatri R. Rao
    Rachel E. Sherman
    Nature Reviews Drug Discovery, 2017, 16 : 737 - 738
  • [24] Quantitative Analysis to Guide Orphan Drug Development
    Lesko, L. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (02) : 258 - 261
  • [25] Biotech innovation boosts orphan drug development
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2008, 21 (07) : 16 - +
  • [26] Flexibility in the FDA approach to orphan drug development
    Hunter, Nina L.
    Rao, Gayatri R.
    Sherman, Rachel E.
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (11) : 737 - 738
  • [27] Orphan Nuclear Receptors as Targets for Drug Development
    Subhajit Mukherjee
    Sridhar Mani
    Pharmaceutical Research, 2010, 27 : 1439 - 1468
  • [28] Advancing orphan drug development for rare diseases
    Ko, Jung Min
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2024, 67 (07) : 356 - 357
  • [29] Orphan drug development is progressing too slowly
    Joppi, R
    Bertele, V
    Garattini, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) : 355 - 360
  • [30] CLINICAL DRUG DEVELOPMENT WITH EMPHASIS ON ORPHAN DISEASES
    Venitz, J.
    MUSCLE & NERVE, 2013, 48 (04) : 692 - 692
12345